DIS3
Basic information
Region (hg38): 13:72752169-72782096
Previous symbols: [ "KIAA1008" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DIS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 37 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 8 | |||||
Total | 0 | 0 | 46 | 5 | 1 |
Variants in DIS3
This is a list of pathogenic ClinVar variants found in the DIS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-72753783-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
13-72753786-G-C | not specified | Uncertain significance (Nov 08, 2022) | ||
13-72755194-C-T | not specified | Uncertain significance (Dec 07, 2021) | ||
13-72755200-A-T | not specified | Uncertain significance (Feb 07, 2023) | ||
13-72755208-A-G | not specified | Uncertain significance (Jan 17, 2024) | ||
13-72755211-C-A | not specified | Uncertain significance (Jan 26, 2023) | ||
13-72759797-A-G | not specified | Likely benign (Nov 12, 2021) | ||
13-72759806-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
13-72759853-T-C | not specified | Uncertain significance (Jan 09, 2024) | ||
13-72760539-A-G | not specified | Uncertain significance (Dec 16, 2022) | ||
13-72760623-A-G | not specified | Uncertain significance (Jul 14, 2021) | ||
13-72761401-T-G | not specified | Uncertain significance (Jun 07, 2024) | ||
13-72761421-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
13-72761466-C-A | not specified | Uncertain significance (Apr 22, 2024) | ||
13-72761481-T-C | not specified | Uncertain significance (Nov 12, 2021) | ||
13-72761500-T-C | not specified | Benign (Jul 19, 2022) | ||
13-72761513-G-C | not specified | Uncertain significance (Dec 02, 2024) | ||
13-72761773-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
13-72761930-T-A | Multiple myeloma | Likely pathogenic (Aug 31, 2019) | ||
13-72761953-A-G | not specified | Uncertain significance (Sep 26, 2024) | ||
13-72762016-T-C | not specified | Uncertain significance (Jan 17, 2023) | ||
13-72762029-G-A | not specified | Uncertain significance (May 27, 2022) | ||
13-72762029-G-T | not specified | Uncertain significance (Feb 26, 2024) | ||
13-72762089-C-G | not specified | Uncertain significance (Aug 05, 2024) | ||
13-72763505-A-G | not specified | Uncertain significance (Jul 21, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DIS3 | protein_coding | protein_coding | ENST00000377767 | 21 | 26695 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.27e-21 | 0.116 | 125493 | 0 | 254 | 125747 | 0.00101 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.693 | 459 | 503 | 0.913 | 0.0000249 | 6295 |
Missense in Polyphen | 141 | 177.47 | 0.79448 | 2176 | ||
Synonymous | -0.469 | 181 | 173 | 1.05 | 0.00000882 | 1772 |
Loss of Function | 1.51 | 39 | 50.6 | 0.771 | 0.00000282 | 628 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00256 | 0.00255 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00109 | 0.00109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.00105 | 0.00104 |
Middle Eastern | 0.00109 | 0.00109 |
South Asian | 0.00114 | 0.00111 |
Other | 0.00198 | 0.00196 |
dbNSFP
Source:
- Function
- FUNCTION: Putative catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. DIS3 has both 3'-5' exonuclease and endonuclease activities. {ECO:0000269|PubMed:19056938, ECO:0000269|PubMed:20531386}.;
- Pathway
- RNA degradation - Homo sapiens (human);Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;mRNA decay by 3, to 5, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.962
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.32
Haploinsufficiency Scores
- pHI
- 0.427
- hipred
- Y
- hipred_score
- 0.714
- ghis
- 0.623
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.485
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dis3
- Phenotype
- vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- rRNA processing;RNA catabolic process;rRNA catabolic process;regulation of mRNA stability;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;CUT catabolic process;RNA phosphodiester bond hydrolysis, exonucleolytic
- Cellular component
- nuclear exosome (RNase complex);cytoplasmic exosome (RNase complex);exosome (RNase complex);nucleus;nucleoplasm;nucleolus;cytosol;membrane
- Molecular function
- 3'-5'-exoribonuclease activity;RNA binding;endonuclease activity;guanyl-nucleotide exchange factor activity;protein binding